Search

Search Constraints

You searched for: Author/Creator Huntsman, David G.

Search Results

1. DICER1 and FOXL2 Mutation Status Correlates With Clinicopathologic Features in Ovarian Sertoli-Leydig Cell Tumors. (May 2019)

2. Confirmation of ProMisE: A simple, genomics‐based clinical classifier for endometrial cancer. Issue 5 (6th January 2017)

4. Use of Immunohistochemical Markers (HNF-1β, Napsin A, ER, CTH, and ASS1) to Distinguish Endometrial Clear Cell Carcinoma From Its Morphologic Mimics Including Arias-Stella Reaction. (July 2020)

5. Estrogen Plus Progestin Hormone Therapy and Ovarian Cancer: A Complicated Relationship Explored. Issue 3 (May 2020)

6. Tubo-Ovarian Transitional Cell Carcinoma and High-grade Serous Carcinoma Show Subtly Different Immunohistochemistry Profiles. (November 2019)

7. Diagnostic Value of Next-Generation Sequencing in an Unusual Sphenoid Tumor. (7th May 2014)

8. Critical questions in ovarian cancer research and treatment: Report of an American Association for Cancer Research Special Conference. Issue 12 (5th March 2019)

9. Diagnostic Value of Next‐Generation Sequencing in an Unusual Sphenoid Tumor. (7th May 2014)

10. Changing Clinical Practice: Evaluation of Implementing Recommendations for Opportunistic Salpingectomy in British Columbia and Ontario. Issue 6 (July 2018)